Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-26-019601
Filing Date
2026-03-18
Accepted
2026-03-18 20:45:57
Documents
4
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1773881151.html 3  
1 FORM 3 wk-form3_1773881151.xml 3 7738
2 EX-24 cbpoa.htm EX-24 5459
3 GRAPHIC cbpoa001.jpg GRAPHIC 238546
4 GRAPHIC cbpoa002.jpg GRAPHIC 96624
  Complete submission text file 0001628280-26-019601.txt   476446
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Issuer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TELIX PHARMACEUTICALS LTD 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address
Behrenbruch Christian (Reporting) CIK: 0002037713 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42128 | Film No.: 26771839